These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12105210)

  • 21. Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice.
    Wiersma H; Gatti A; Nijstad N; Kuipers F; Tietge UJ
    J Lipid Res; 2009 Aug; 50(8):1571-80. PubMed ID: 19252221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism.
    Li Y; Bolten C; Bhat BG; Woodring-Dietz J; Li S; Prayaga SK; Xia C; Lala DS
    Mol Endocrinol; 2002 Mar; 16(3):506-14. PubMed ID: 11875109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.
    Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
    J Lipid Res; 2006 Feb; 47(2):421-30. PubMed ID: 16264196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice.
    Tang W; Ma Y; Jia L; Ioannou YA; Davies JP; Yu L
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):448-54. PubMed ID: 18187667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo.
    Escolà-Gil JC; Julve J; Llaverias G; Urpi-Sarda M; Silvennoinen R; Lee-Rueckert M; Andres-Lacueva C; Blanco-Vaca F
    Transl Res; 2013 Feb; 161(2):110-7. PubMed ID: 23146569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein.
    Xie Y; Kennedy S; Sidhu R; Luo J; Ory DS; Davidson NO
    Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1624-31. PubMed ID: 22580900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
    J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes.
    Liang Y; Lin S; Beyer TP; Zhang Y; Wu X; Bales KR; DeMattos RB; May PC; Li SD; Jiang XC; Eacho PI; Cao G; Paul SM
    J Neurochem; 2004 Feb; 88(3):623-34. PubMed ID: 14720212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.
    Liang G; Yang J; Horton JD; Hammer RE; Goldstein JL; Brown MS
    J Biol Chem; 2002 Mar; 277(11):9520-8. PubMed ID: 11782483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol status.
    Tamehiro N; Shigemoto-Mogami Y; Kakeya T; Okuhira K; Suzuki K; Sato R; Nagao T; Nishimaki-Mogami T
    J Biol Chem; 2007 Jul; 282(29):21090-9. PubMed ID: 17526932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
    Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
    Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist.
    Kaneko E; Matsuda M; Yamada Y; Tachibana Y; Shimomura I; Makishima M
    J Biol Chem; 2003 Sep; 278(38):36091-8. PubMed ID: 12847102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
    Breevoort SR; Angdisen J; Schulman IG
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice.
    Wiersma H; Gatti A; Nijstad N; Oude Elferink RP; Kuipers F; Tietge UJ
    Hepatology; 2009 Oct; 50(4):1263-72. PubMed ID: 19637290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.
    Zanotti I; Potì F; Pedrelli M; Favari E; Moleri E; Franceschini G; Calabresi L; Bernini F
    J Lipid Res; 2008 May; 49(5):954-60. PubMed ID: 18252848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol.
    Heverin M; Meaney S; Brafman A; Shafir M; Olin M; Shafaati M; von Bahr S; Larsson L; Lövgren-Sandblom A; Diczfalusy U; Parini P; Feinstein E; Björkhem I
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2191-7. PubMed ID: 17761942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression.
    Wagner BL; Valledor AF; Shao G; Daige CL; Bischoff ED; Petrowski M; Jepsen K; Baek SH; Heyman RA; Rosenfeld MG; Schulman IG; Glass CK
    Mol Cell Biol; 2003 Aug; 23(16):5780-9. PubMed ID: 12897148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.